
RDHL
Healthcare · Drug Manufacturers - Specialty & Generic · $3.3M market cap
$0.3750-0.01 (-1.6%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 12, 2026 | Time not confirmed | — | 0.00 | — |
| Dec 2, 2025 | Time not confirmed | — | 0.00 | — |
| Sep 5, 2025 | Time not confirmed | — | -2.29 | — |
| Apr 10, 2025 | Time not confirmed | — | -4.02 | — |
| Mar 31, 2025 | Time not confirmed | — | -4.02 | — |
| Nov 29, 2024 | Time not confirmed | — | 0.00 | — |
| Aug 29, 2024 | Before the open | -30.00 | -200.00 | -566.7% |
| Apr 8, 2024 | Before the open | -0.03 | -0.20 | -566.7% |
| Feb 12, 2024 | Before the open | -0.03 | -0.20 | -566.7% |
| Nov 15, 2023 | Time not confirmed | — | 0.00 | — |
| Aug 17, 2023 | Before the open | — | 0.26 | — |
| Apr 28, 2023 | Before the open | — | -1.60 | — |
| Mar 27, 2023 | Time not confirmed | 0.00 | -0.20 | — |
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients…
| Nov 29, 2022 |
| Before the open |
| -10.00 |
| -60.00 |
| -500.0% |
| Sep 23, 2022 | After the close | -0.03 | -0.20 | -566.7% |
| Jun 23, 2022 | Before the open | -30.00 | -30.00 | 0.0% |
| Mar 17, 2022 | Before the open | -430.00 | -500.00 | -16.3% |
| Nov 30, 2021 | Before the open | -282.00 | -50.00 | +82.3% |
| Aug 26, 2021 | Before the open | -248.00 | -600.00 | -141.9% |
| May 27, 2021 | Before the open | -278.00 | -500.00 | -79.9% |
| Mar 18, 2021 | Before the open | -0.24 | -0.70 | -191.7% |
| Nov 12, 2020 | Before the open | -185.00 | -499.82 | -170.2% |
| Aug 13, 2020 | Before the open | -90.00 | -40.00 | +55.6% |
| May 27, 2020 | Before the open | -600.00 | -500.00 | +16.7% |
| Mar 4, 2020 | Before the open | -237.50 | -300.00 | -26.3% |
| Nov 19, 2019 | Before the open | -292.50 | -300.00 | -2.6% |
| Jul 23, 2019 | Before the open | -346.67 | -400.00 | -15.4% |
| May 7, 2019 | Before the open | -346.67 | -300.00 | +13.5% |
| Feb 26, 2019 | Before the open | -0.38 | -0.30 | +21.1% |
| Nov 13, 2018 | Before the open | -413.33 | -400.00 | +3.2% |
| Aug 30, 2018 | Before the open | -0.44 | -0.50 | -13.6% |
| May 8, 2018 | Before the open | -463.33 | -500.00 | -7.9% |
| Feb 22, 2018 | Before the open | -0.60 | -0.50 | +16.7% |